EMERGING PUBLIC BIOTECH

AMPHASTAR PHARMACEUTICALS INC (AMPH)

Rancho Cucamonga, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Rancho Cucamonga, United States
TICKER
AMPH
SEGMENT
Emerging Public Biotech
THERAPY AREAS
KEY PRODUCTS
PRODUCTDETAILS
Baqsimi
COMPANY OVERVIEW

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase…

AMPHASTAR PHARMACEUTICALS INC — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →